✦ LIBER ✦

Abacavir and Cardiovascular Risk: Reviewing the Evidence

✍ Scribed by Dominique Costagliola; Sylvie Lang; Murielle Mary-Krause; Franck Boccara

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipids, lipid modifying agents and cardi

✍ David Preiss; Naveed Sattar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB

Pre-Diabetes and the Risk for Cardiovasc

✍ Earl S. Ford; Guixiang Zhao; Chaoyang Li 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 537 KB

C-Reactive Protein in Cardiovascular Ris

✍ Jacob Abraham; Catherine Y. Campbell; Aamir Cheema; Ty J. Gluckman; Roger S. Blu 📂 Article 📅 2007 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 758 KB

Abacavir and the potential risk of myoca

✍ Amy Cutrell; Cindy Brothers; Jane Yeo; Jamie Hernandez; Didier Lapierre 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 45 KB

Modification of cardiovascular risk in h

✍ David W. JOHNSON; Ann-Maree CRAVEN; Nicole Maree ISBEL 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

Field independence: Reviewing the eviden

✍ Evans, Carol; Richardson, John T. E.; Waring, Michael 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB